STELARA

STELARA

Displaying 10 out of 1 results

  1. FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75

    Prescription drugs boost drives J&J forecasts higher, shares rise

    Johnson & Johnson on Tuesday posted a 22.9per cent rise in third-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.